200 related articles for article (PubMed ID: 32113841)
1. Discovery of 4-((1-(1H-imidazol-2-yl)alkoxy)methyl)pyridines as a new class of Trypanosoma cruzi growth inhibitors.
Ponzi S; Bresciani A; Kaiser M; Nardi V; Nizi E; Ontoria JM; Pace P; Paonessa G; Summa V; Harper S
Bioorg Med Chem Lett; 2020 Apr; 30(8):127052. PubMed ID: 32113841
[TBL] [Abstract][Full Text] [Related]
2. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
[TBL] [Abstract][Full Text] [Related]
3. 8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi.
Fersing C; Boudot C; Castera-Ducros C; Pinault E; Hutter S; Paoli-Lombardo R; Primas N; Pedron J; Seguy L; Bourgeade-Delmas S; Sournia-Saquet A; Stigliani JL; Brossas JY; Paris L; Valentin A; Wyllie S; Fairlamb AH; Boutet-Robinet É; Corvaisier S; Since M; Malzert-Fréon A; Destere A; Mazier D; Rathelot P; Courtioux B; Azas N; Verhaeghe P; Vanelle P
Eur J Med Chem; 2020 Sep; 202():112558. PubMed ID: 32652409
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.
Balfour MN; Franco CH; Moraes CB; Freitas-Junior LH; Stefani HA
Eur J Med Chem; 2017 Mar; 128():202-212. PubMed ID: 28189084
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi.
Sijm M; Sterk GJ; Caljon G; Maes L; de Esch IJP; Leurs R
ChemMedChem; 2020 Jul; 15(14):1310-1321. PubMed ID: 32249532
[TBL] [Abstract][Full Text] [Related]
7. Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: Synthesis, in vitro and in vivo studies.
Ribeiro JLS; Soares JCAV; Portapilla GB; Providello MV; Lima CHS; Muri EMF; de Albuquerque S; Dias LRS
Bioorg Med Chem; 2021 Jan; 29():115855. PubMed ID: 33199200
[TBL] [Abstract][Full Text] [Related]
8. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
10. Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives.
Vieira DF; Choi JY; Roush WR; Podust LM
Chembiochem; 2014 May; 15(8):1111-20. PubMed ID: 24771705
[TBL] [Abstract][Full Text] [Related]
11. Dual Parasiticidal Activities of Phthalimides: Synthesis and Biological Profile against Trypanosoma cruzi and Plasmodium falciparum.
Teixeira de Moraes Gomes PA; Veríssimo de Oliveira Cardoso M; Dos Santos IR; Amaro de Sousa F; da Conceição JM; Gouveia de Melo Silva V; Duarte D; Pereira R; Oliveira R; Nogueira F; Alves LC; Brayner FA; da Silva Santos AC; Rêgo Alves Pereira V; Lima Leite AC
ChemMedChem; 2020 Nov; 15(22):2164-2175. PubMed ID: 32813331
[TBL] [Abstract][Full Text] [Related]
12. An aromatic imidazoline derived from chloroquinoline triggers cell cycle arrest and inhibits with high selectivity the Trypanosoma cruzi mammalian host-cells infection.
Cuevas-Hernández RI; Girard RMBM; Krstulović L; Bajić M; Silber AM
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009994. PubMed ID: 34843481
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.
Chen CK; Doyle PS; Yermalitskaya LV; Mackey ZB; Ang KK; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2009; 3(2):e372. PubMed ID: 19190730
[TBL] [Abstract][Full Text] [Related]
14. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and 2D-QSAR studies of neolignan-based diaryl-tetrahydrofuran and -furan analogues with remarkable activity against Trypanosoma cruzi and assessment of the trypanothione reductase activity.
Hartmann AP; de Carvalho MR; Bernardes LSC; Moraes MH; de Melo EB; Lopes CD; Steindel M; da Silva JS; Carvalho I
Eur J Med Chem; 2017 Nov; 140():187-199. PubMed ID: 28926763
[TBL] [Abstract][Full Text] [Related]
16. In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51.
De Vita D; Moraca F; Zamperini C; Pandolfi F; Di Santo R; Matheeussen A; Maes L; Tortorella S; Scipione L
Eur J Med Chem; 2016 May; 113():28-33. PubMed ID: 26922226
[TBL] [Abstract][Full Text] [Related]
17. Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides.
Russell S; Rahmani R; Jones AJ; Newson HL; Neilde K; Cotillo I; Rahmani Khajouei M; Ferrins L; Qureishi S; Nguyen N; Martinez-Martinez MS; Weaver DF; Kaiser M; Riley J; Thomas J; De Rycker M; Read KD; Flematti GR; Ryan E; Tanghe S; Rodriguez A; Charman SA; Kessler A; Avery VM; Baell JB; Piggott MJ
J Med Chem; 2016 Nov; 59(21):9686-9720. PubMed ID: 27548560
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitrypanosomal activities of novel pyridylchalcones.
Bhambra AS; Ruparelia KC; Tan HL; Tasdemir D; Burrell-Saward H; Yardley V; Beresford KJM; Arroo RRJ
Eur J Med Chem; 2017 Mar; 128():213-218. PubMed ID: 28189085
[TBL] [Abstract][Full Text] [Related]
20. Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
Pereira GAN; da Silva EB; Braga SFP; Leite PG; Martins LC; Vieira RP; Soh WT; Villela FS; Costa FMR; Ray D; de Andrade SF; Brandstetter H; Oliveira RB; Caffrey CR; Machado FS; Ferreira RS
Eur J Med Chem; 2019 Oct; 179():765-778. PubMed ID: 31284086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
